• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Pain Management

Medtronic reports positive results from spinal cord stimulation trial

October 20, 2020 By Sean Whooley

Medtronic (NYSE:MDT) announced today that it posted positive 12-month results validating the superiority of its DTM spinal cord stimulation (SCS). Fridley, Minn.-based Medtronic’s multicenter, randomized controlled trial produced statistically significant 12-month data that validated the DTM SCS’ (using the Medtronic Intellis platform) superiority in providing relief for back pain when compared to conventional SCS therapy, according […]

Filed Under: Clinical Trials, Featured, Neuromodulation/Neurostimulation, Orthopedics, Pain Management, Spine Tagged With: Medtronic

The top 10 medical disruptors of 2021

October 6, 2020 By Danielle Kirsh

For the past 18 years, the Cleveland Clinic has predicted what the top 10 medical disruptors will be for the following year. The list of technologies, cultivated by a panel of physicians and scientists at the clinic, was led by Dr. Will Morris, executive medical director of Cleveland Clinic Innovations, and Dr. Akhil Saklecha, managing […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Diagnostics, Featured, Hospital Care, Imaging, Implants, Neuromodulation/Neurostimulation, Oncology, Pain Management, Patient Monitoring, Pediatrics, Pharmaceutical, Respiratory, Structural Heart, Structural Heart Tagged With: Cleveland Clinic, coronavirus, COVID-19

Abbott enrolls first patient in spinal cord stimulation study

October 1, 2020 By Sean Whooley

Abbott (NYSE:ABT) announced that it enrolled the first patient in its Distinct study to investigate its BurstDR spinal cord stimulation (SCS). The Distinct (dorsal spinal cord stimulation vs. medical management for treatment of low back pain) study seeks to investigate the efficacy of BurstDR SCS compared with conventional medical management (CMM) in people with chronic low […]

Filed Under: Clinical Trials, Neuromodulation/Neurostimulation, Pain Management Tagged With: Abbott

Boston Scientific launches spinal cord stimulator systems in Europe

October 1, 2020 By Sean Whooley

Boston Scientific (NYSE:BSX) announced that it launched its WaveWriter Alpha spinal cord stimulator (SCS) system portfolio in Europe. Marlborough, Mass.-based Boston Scientific’s portfolio includes four MRI-conditional, Bluetooth-enabled implantable pulse generators (IPGs) and offers expanded personalization, rechargeable and non-rechargeable options and access to waveforms covering multiple areas of pain, according to a news release. SCS therapies relieve […]

Filed Under: Business/Financial News, Featured, Neuromodulation/Neurostimulation, Pain Management Tagged With: Boston Scientific, CE Mark

NeuroMetrix launches Quell app for Apple Watch

September 23, 2020 By Sean Whooley

NeuroMetrix (NSDQ:NURO) announced that it launched the Quell Watch App for transcutaneous electrical nerve stimulation (TENS). Woburn, Mass.-based NeuroMetrix’s Quell app, which is now available for download from the Apple App Store, allows users of the Quell system to personalize and manage their therapy discreetly on iPhone and Android smartphones, according to a news release. Quell […]

Filed Under: Business/Financial News, Health Technology, Neuromodulation/Neurostimulation, Pain Management, Patient Monitoring, Software / IT Tagged With: Neurometrix

FTC to refund Neurometrix consumers $3.9M in false ad case

September 9, 2020 By Sean Whooley

The Federal Trade Commission announced that it is refunding NeuroMetrix (NSDQ:NURO) consumers nearly $3.9 million after false advertising. NeuroMetrix marketed its Quell transcutaneous electrical nerve stimulation device as a clinically proven and FDA-cleared treatment for widespread chronic pain relief when placed below the knee, according to the FTC, which said that the company lacks scientific evidence […]

Filed Under: Business/Financial News, Featured, Legal News, Neuromodulation/Neurostimulation, Pain Management Tagged With: Federal Trade Commission (FTC), Neurometrix

Theranica lands CE mark for migraine device

September 8, 2020 By Sean Whooley

Theranica announced today that it received CE Mark approval for its Nerivio device for the acute treatment of migraine. Montclair, N.J.-based Theranica adds European approval just over a year since it received FDA de novo clearance for the neurostimulation device in May 2019. The approval allows for the company to begin marketing the device in […]

Filed Under: Health Technology, Neurological, Neuromodulation/Neurostimulation, Pain Management, Software / IT Tagged With: CE Mark, Theranica Bio-Electronics

The 18 most innovative medical devices of 2020

July 24, 2020 By Danielle Kirsh

The Galien Foundation recently announced nominees for most innovative medical devices for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical and technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien process, we are honored […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Endoscopic, Featured, Implants, Oncology, Pain Management, Patient Monitoring, Respiratory, Structural Heart, Vascular, Vision Tagged With: Abbott, BD, Biotronik, Boston Scientific, Edwards Lifesciences, endomag, Glaukos, Impulse Dynamics, Medtronic, Pear Therapeutics, Prix Galien USA, Pulmonx, Sonendo, Teva Pharmaceuticals

People can now control their Abbott neuromod device over their iPhone

July 23, 2020 By Sean Whooley

Abbott (NYSE:ABT) announced today that it received FDA approval for the use of its Patient Controller app on compatible Apple smartphone devices. The company’s Patient Controller app offers management tools for patients with implanted neuromodulation devices to treat conditions such as chronic pain or movement disorders. Now, with the latest approval from the FDA, it’s possible […]

Filed Under: Digital Health, Featured, Food & Drug Administration (FDA), Health Technology, Neuromodulation/Neurostimulation, Pain Management, Patient Monitoring, Regulatory/Compliance, Software / IT Tagged With: Abbott, FDA

NeuroMetrix improves bottom line despite nearly halved Q2 sales

July 23, 2020 By Sean Whooley

NeuroMetrix (NSDQ:NURO) shares dipped today after posting second-quarter results that reflected the effects of the COVID-19 pandemic. The Woburn, Mass.-based pain-treating transcutaneous electrical nerve stimulation (TENS) device developer posted losses of -$851,944 on sales of $$1.4 million for the three months ended June 30, 2020, for a 74.7% bottom-line gain on a sales decline of 42.2%. […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Neuromodulation/Neurostimulation, Pain Management, Wall Street Beat Tagged With: Neurometrix

FDA approves Mainstay Medical neurostim device

June 23, 2020 By Sean Whooley

Mainstay Medical announced that it received FDA premarket approval for its ReActiv8 implantable neurostimulation system for chronic low back pain. ReActiv8 treats intractable chronic low back pain associated with multifidus muscle dysfunction, as evidenced by imaging or physiological testing in adults who have failed therapy and are not candidates for spine surgery, according to a […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Implants, Neurological, Neuromodulation/Neurostimulation, Pain Management, Pre-Market Approval (PMA), Regulatory/Compliance, Spine Tagged With: FDA, Mainstay Medical

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 37
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS